- •Foreword
- •Preface
- •List of Contributors
- •Acknowledgments
- •Dedication
- •In Memorium
- •DEFINITIONS
- •EPIDEMIOLOGIC AND SOCIOECONOMIC ASPECTS OF THE GLAUCOMAS
- •RISK FACTORS
- •CLASSIFICATION OF THE GLAUCOMAS
- •REFERENCES
- •Aqueous humor formation
- •FUNCTION OF AQUEOUS HUMOR
- •ANATOMY OF THE CILIARY BODY
- •STRUCTURE
- •ULTRASTRUCTURE OF THE CILIARY PROCESSES
- •VASCULAR SUPPLY
- •MECHANISM OF AQUEOUS FORMATION
- •ULTRAFILTRATION
- •ACTIVE TRANSPORT
- •DIFFUSION
- •CHEMICAL COMPOSITION OF THE AQUEOUS HUMOR
- •THE BLOOD–AQUEOUS BARRIER
- •PRESSURE-DEPENDENT TECHNIQUES
- •Tonography
- •Suction cup
- •Perfusion
- •TRACER METHODS
- •Photogrammetry
- •Radiolabeled isotopes
- •Fluorescein
- •Fluoresceinated dextrans
- •Paraminohippurate
- •Iodide
- •FACTORS AFFECTING AQUEOUS HUMOR FORMATION
- •DIURNAL VARIATION
- •INTRAOCULAR PRESSURE/PSEUDOFACILITY
- •BLOOD FLOW TO THE CILIARY BODY
- •NEURAL CONTROL
- •HORMONAL EFFECTS
- •INTRACELLULAR REGULATORS
- •CLINICAL ASPECTS OF AQUEOUS HUMOR FORMATION
- •CLINICAL CONDITIONS
- •PHARMACOLOGIC AGENTS
- •SURGERY
- •REFERENCES
- •PHYSIOLOGY ISSUES UNIQUE TO THE CONVENTIONAL AQUEOUS OUTFLOW SYSTEM
- •FUNCTIONS OF THE CONVENTIONAL AQUEOUS OUTFLOW SYSTEM
- •ANATOMY OF THE CONVENTIONAL OUTFLOW SYSTEM
- •SCHWALBE’S LINE
- •SCLERAL SPUR
- •TRABECULAR MESHWORK TISSUES
- •Uveal meshwork
- •Corneoscleral meshwork
- •Uveal and corneoscleral meshwork ultrastructure
- •Juxtacanalicular space and cells
- •SCHLEMM’S CANAL
- •Overview
- •Schlemm’s canal inner wall endothelium
- •Glycocalyx
- •Distending cells that form invaginations or pseudovacuoles, ‘giant vacuoles’
- •Schlemm’s canal endothelium pores
- •Sonderman’s canals invaginate into the trabecular meshwork
- •Septa
- •Schlemm’s canal valves spanning across Schlemm’s canal
- •Herniations or protrusions of Schlemm’s canal inner wall
- •Collector channels, aqueous veins and episcleral veins
- •RESISTANCE SITES IN THE AQUEOUS OUTFLOW SYSTEM
- •JUXTACANALICULAR SPACE RESISTANCE
- •SCHLEMM’S CANAL ENDOTHELIUM RESISTANCE
- •PRINCIPLES OF BIOMECHANICS AS A METHODOLOGY TO IDENTIFY TISSUE RESISTANCE
- •TISSUE LOADING STUDIES
- •BOUNDARY CONDITIONS
- •EVIDENCE FROM EXPERIMENTAL MICROSURGERY
- •AQUEOUS OUTFLOW PHYSIOLOGY: PASSIVE AND DYNAMIC FLOW MODELS
- •THE AQUEOUS OUTFLOW SYSTEM AS A PASSIVE FILTER
- •THE AQUEOUS OUTFLOW SYSTEM AS A DYNAMIC MECHANICAL PUMP
- •EXTRINSIC PRESSURE REGULATION MECHANISMS
- •UVEOSCLERAL FLOW
- •METHODS FOR MEASURING FACILITY OF OUTFLOW
- •FACILITY OF OUTFLOW CALCULATIONS
- •Tonography
- •Perfusion
- •Suction cup
- •FACILITY OF OUTFLOW AND ITS CLINICAL IMPLICATIONS
- •FACTORS AFFECTING THE FACILITY OF OUTFLOW
- •HORMONES
- •CILIARY MUSCLE TONE
- •DRUGS
- •SURGICAL THERAPY
- •DIURNAL FLUCTUATION
- •GLAUCOMA
- •EPISCLERAL VENOUS PRESSURE
- •REFERENCES
- •Intraocular pressure
- •INSTRUMENTS FOR MEASURING INTRAOCULAR PRESSURE
- •APPLANATION INSTRUMENTS
- •Goldmann tonometer
- •Perkins tonometer
- •Draeger tonometer
- •MacKay-Marg and Tono-Pen™ tonometers
- •Pneumatic tonometer
- •Non-contact tonometer
- •The Ocuton™ tonometer
- •Maklakow tonometer
- •INDENTATION INSTRUMENTS
- •Schiøtz tonometer
- •Electronic Schiøtz tonometer
- •Impact–rebound tonometer
- •Transpalpebral tonometry
- •DYNAMIC CONTOUR TONOMETRY
- •CONTINUOUS MONITORING OF INTRAOCULAR PRESSURE
- •SUMMARY OF TONOMETRY
- •DISTRIBUTION OF INTRAOCULAR PRESSURE IN THE GENERAL POPULATION
- •FACTORS THAT INFLUENCE INTRAOCULAR PRESSURE
- •RACE
- •HEREDITY
- •DIURNAL VARIATION
- •SEASONAL VARIATION
- •CARDIOVASCULAR FACTORS
- •EXERCISE
- •WIND INSTRUMENT PLAYING
- •LIFESTYLE
- •POSTURAL CHANGES
- •NEURAL FACTORS
- •PSYCHIATRIC DISORDERS
- •HORMONAL FACTORS
- •REFRACTIVE ERROR
- •FOODS AND DRUGS
- •MISCELLANEOUS
- •EYE MOVEMENTS
- •EYELID CLOSURE
- •INFLAMMATION
- •SURGERY
- •REFERENCES
- •Gonioscopic anatomy
- •GROSS ANATOMY
- •ANATOMIC FEATURES OF NORMAL EYES
- •GONIOSCOPIC ANATOMY AND MICROSCOPIC INTERPRETATION
- •PUPIL AND IRIS
- •CILIARY BODY, IRIS PROCESSES, AND SYNECHIAE
- •SCLERAL SPUR
- •SCHWALBE’S LINE
- •TRABECULAR MESHWORK AND TRABECULAR PIGMENT BAND
- •GONIOSCOPIC APPEARANCE
- •REFERENCES
- •Methods of gonioscopy
- •DEFINITION
- •METHODS OF GONIOSCOPY
- •EQUIPMENT
- •Goldmann and Zeiss lenses (indirect method)
- •Koeppe lens (direct method)
- •TECHNIQUE
- •Indirect gonioscopic lenses
- •Indentation (compression) gonioscopy
- •Direct gonioscopic lens
- •REFERENCES
- •GRADING OF CHAMBER ANGLE
- •DIAGRAMMING ANGLE WIDTH, SYNECHIAE, AND PIGMENTATION
- •TRABECULAR PIGMENT BAND
- •SPAETH CLASSIFICATION
- •STEP 4: TRABECULAR MESHWORK PIGMENTATION
- •EXAMPLES
- •DIFFICULTIES AND ARTIFACTS IN GONIOSCOPY
- •CLINICAL USEFULNESS OF GONIOSCOPY
- •AID IN DIAGNOSIS OF TYPE OF GLAUCOMA
- •EVALUATION OF SYMPTOMS
- •USE OF DRUGS
- •POSTOPERATIVE EXAMINATIONS
- •CONDITIONS OTHER THAN GLAUCOMA
- •SUMMARY OF IMPORTANT GONIOSCOPIC TECHNIQUES
- •REFERENCES
- •APPENDIX
- •Visual field theory and methods
- •THE NORMAL VISUAL FIELD
- •VISUAL ACUITY VERSUS VISUAL FIELD
- •TERMINOLOGY AND DEFINITIONS
- •THEORY OF VISUAL FIELD TESTING
- •KINETIC PERIMETRY
- •STATIC PERIMETRY
- •THRESHOLD-RELATED TESTING
- •ZONE TESTING
- •SCREENING TESTS
- •OTHER STATIC TESTING TECHNIQUES
- •THE FUTURE OF VISUAL FIELD TESTING
- •COMBINED STATIC AND KINETIC PERIMETRY
- •REFERENCES
- •PATIENT VARIABLES
- •FIXATION
- •RELIABILITY
- •OCULAR VARIABLES
- •PUPIL SIZE
- •MEDIA CLARITY
- •REFRACTIVE CORRECTION
- •TESTING VARIABLES
- •TECHNICIAN
- •BACKGROUND ILLUMINATION
- •STIMULUS SIZE AND INTENSITY
- •STIMULUS EXPOSURE TIME
- •AREA TESTED
- •EQUIPMENT AND TECHNIQUES
- •GENERAL PRINCIPLES
- •TANGENT SCREEN
- •BOWL PERIMETRY
- •Preparing the patient
- •Technique of computerized bowl perimetry
- •REFERENCES
- •Visual field interpretation
- •GLAUCOMATOUS CHANGES IN THE VISUAL FIELD
- •ANATOMY OF VISUAL FIELD DEFECTS
- •TYPES OF VISUAL FIELD LOSS
- •Generalized loss
- •Localized defects (scotomata)
- •GLAUCOMATOUS VISUAL FIELD DEFECTS
- •Generalized depression
- •Irregularity of the visual field
- •Nasal step or depression
- •Temporal step or depression
- •Enlargement of the blind spot
- •Isolated paracentral scotomata
- •Arcuate defects (nerve fiber bundle defects)
- •End-stage defects
- •Central and temporal islands
- •Reversal of visual field defects
- •ANALYSIS OF VISUAL FIELD LOSS
- •CHRONIC OPEN-ANGLE GLAUCOMA
- •ANGLE-CLOSURE GLAUCOMA
- •OTHER CAUSES
- •ESTERMAN DISABILITY RATING
- •ANALYSIS OF COMPUTERIZED STATIC PERIMETRY
- •RELIABILITY INDEXES
- •False-positive and false-negative responses
- •Fixation reliability
- •FLUCTUATION
- •Short-term fluctuation
- •Long-term fluctuation
- •GLOBAL INDEXES
- •Mean sensitivity
- •Mean deviation or defect
- •Standard deviation or variance
- •GRAPHIC PLOTS
- •AREA OF THE VISUAL FIELD TO BE TESTED
- •LONG-TERM ANALYSIS
- •DETERMINATION OF NORMAL VISUAL FIELD
- •DEVIATION FROM NORMAL VALUES
- •Graphic plot of points varying from normal
- •Global indexes
- •Comparison with the other eye
- •Localized variation within the visual field
- •RECOGNITION OF CHANGE
- •QUANTIFYING VISUAL FIELD CHANGE
- •THE FUTURE OF COMPUTERIZED PERIMETRY
- •REFERENCES
- •Other psychophysical tests
- •INTRODUCTION
- •COLOR VISION AND SHORT-WAVELENGTH AUTOMATED PERIMETRY
- •FREQUENCY-DOUBLING PERIMETRY
- •OTHER PSYCHOPHYSICAL TESTS
- •HIGH-PASS RESOLUTION PERIMETRY
- •MOTION DETECTION PERIMETRY
- •ELECTROPHYSIOLOGY
- •The electroretinogram (ERG)
- •The pattern electroretinogram (PERG)
- •The multifocal electroretinogram (mfERG)
- •The multifocal visual-evoked potential (mfVEP)
- •REFERENCES
- •ANATOMY OF THE OPTIC NERVE HEAD
- •WHERE ARE THE GANGLION CELLS INJURED?
- •WHAT INJURES GANGLION CELLS?
- •Ganglion Cell Susceptibility
- •Connective tissue structures within the optic nerve head
- •Vascular nutrition of the optic disc
- •REFERENCES
- •CLINICAL TECHNIQUES OF EVALUATION
- •OPTIC DISC CHANGES IN GLAUCOMA
- •INTRAPAPILLARY DISC CHANGES
- •Optic disc size
- •Optic disc shape
- •Neuroretinal rim size (NRR)
- •Neuroretinal rim shape
- •Optic cup size in relation to optic disc size
- •Optic cup configuration and depth
- •Cup:disc ratios
- •Position of central retinal vessels and branches
- •PERIPAPILLARY DISC CHANGES
- •Optic disc hemorrhages
- •Nerve fiber layer defects
- •Diameter of retinal arterioles
- •Peripapillary choroidal atrophy
- •PATTERNS OF OPTIC NERVE CHANGES AND SUBTYPES OF GLAUCOMA
- •HIGH MYOPIA DISC PATTERN
- •FOCAL NORMAL-PRESSURE PATTERN (FOCAL ISCHEMIC)
- •AGE-RELATED ATROPHIC PRIMARY OPEN-ANGLE GLAUCOMA PATTERN (SENILE SCLEROTIC)
- •JUVENILE OPEN-ANGLE GLAUCOMA PATTERN
- •PRIMARY OPEN-ANGLE GLAUCOMA PATTERN (GENERALIZED ENLARGEMENT)
- •REFERENCES
- •Optic nerve imaging
- •CONFOCAL SCANNING LASER OPHTHALMOSCOPY (CSLO)
- •HEIDELBERG RETINA TOMOGRAPHY (HRT)
- •Components of the HRT report
- •Evaluating scan quality
- •Strengths and limitations
- •New developments
- •Testing from the patient’s perspective
- •OPTICAL COHERENCE TOMOGRAPHY (OCT)
- •DIFFERENT SCANNING MODALITIES
- •Peripapillary scan
- •Macular scan
- •ONH scan
- •Fast scans
- •COMPONENTS OF THE OCT REPORT
- •RNFL thickness average analysis
- •Macular analysis
- •Optic nerve head analysis
- •QUALITY ASSESSMENT
- •STRENGTHS AND LIMITATIONS
- •TESTING FROM THE PATIENT’S PERSPECTIVE
- •LONGITUDINAL EVALUATIONS
- •SCANNING LASER POLARIMETRY
- •Components of the GDX report
- •Quality assessment
- •Strengths and limitations
- •Testing from the patient’s perspective
- •CONCLUSIONS
- •REFERENCES
- •Primary angle-closure glaucoma
- •HISTORICAL REVIEW AND CLASSIFICATIONS
- •CLASSIFICATIONS OF ANGLE-CLOSURE DISEASE
- •TWENTY-FIRST CENTURY CONSENSUS CLASSIFICATION
- •CLARIFICATIONS AND COMMENTARY
- •PRESENTATIONS OF PRIMARY ANGLE-CLOSURE DISEASE
- •NEW IMAGING TECHNOLOGIES
- •CLASSIFICATION BY MECHANISMS IN THE ANTERIOR SEGMENT
- •PUPILLARY BLOCK GLAUCOMA
- •Epidemiologic studies
- •Demographic risk factors
- •Gender
- •Heredity
- •Refractive error
- •Miscellaneous factors
- •Ocular risk factors and mechanisms
- •Iris bowing and lens–iris channel
- •Provocative tests
- •Clinical presentations of acute PACG with pupillary block
- •Signs and symptoms
- •Clinical examination
- •Treatment of acute PACG
- •Medical management of acute PACG
- •Slit-lamp maneuvers in management of acute PACG
- •Laser interventions for acute PACG
- •Surgical management of PACG
- •Management of the fellow eye
- •Sequelae of acute PACG
- •Correlating older and newer terminologies for angle closure
- •PLATEAU IRIS
- •Plateau iris configuration
- •Plateau iris syndrome
- •Pseudoplateau iris (cysts of the iris and ciliary body)
- •PHACOMORPHIC GLAUCOMA
- •Intumescent and swollen lens
- •REFERENCES
- •OVERVIEW OF TERMS AND MECHANISMS
- •ANTERIOR PULLING MECHANISM
- •NEOVASCULAR GLAUCOMA
- •Histopathology
- •Pathogenesis
- •Conditions and diseases commonly associated with neovascular glaucoma
- •Diabetes mellitus
- •Central retinal vein occlusion
- •Carotid occlusive disease
- •Ocular ischemic syndrome
- •Central retinal artery occlusion
- •Miscellaneous
- •Clinical presentation
- •Treatment
- •IRIDOCORNEAL ENDOTHELIAL SYNDROME
- •Histopathology
- •Pathogenesis
- •Clinical presentation
- •Progressive (essential) iris atrophy
- •Chandler’s syndrome
- •Cogan-Reese syndrome
- •Treatment
- •POSTERIOR POLYMORPHOUS DYSTROPHY
- •Histopathology
- •Pathogenesis
- •Clinical presentation
- •Treatment
- •EPITHELIAL DOWNGROWTH
- •Pathophysiology
- •Histopathology
- •Clinical presentation
- •Treatment
- •FIBROVASCULAR INGROWTH
- •FLAT ANTERIOR CHAMBER
- •INFLAMMATION
- •PENETRATING KERATOPLASTY
- •IRIDOSCHISIS
- •ANIRIDIA
- •POSTERIOR PUSHING (OR ROTATIONAL) MECHANISM
- •CILIARY BLOCK GLAUCOMA (AQUEOUS MISDIRECTION OR MALIGNANT GLAUCOMA)
- •INTRAOCULAR TUMORS
- •NANOPHTHALMOS
- •SUPRACHOROIDAL HEMORRHAGE
- •POSTERIOR SEGMENT INFLAMMATORY DISEASE
- •Treatment
- •CENTRAL RETINAL VEIN OCCLUSION
- •SCLERAL BUCKLING PROCEDURE
- •PANRETINAL PHOTOCOAGULATION
- •RETINOPATHY OF PREMATURITY
- •PUPILLARY BLOCK MECHANISMS
- •Secondary pupillary block glaucoma: iris–lens adhesions
- •Dislocated and subluxed lens
- •Ectopia lentis
- •Microspherophakia
- •REFERENCES
- •Primary open angle glaucoma
- •EPIDEMIOLOGY
- •PREVALENCE
- •PATHOPHYSIOLOGY
- •DIMINISHED AQUEOUS HUMOR OUTFLOW FACILITY
- •Altered corticosteroid metabolism
- •Dysfunctional adrenergic control
- •Abnormal immunologic processes
- •Oxidative damage
- •Other toxic influences
- •OPTIC NERVE CUPPING AND ATROPHY
- •CLINICAL FEATURES
- •FINDINGS
- •DIFFERENTIAL DIAGNOSIS
- •TREATMENT
- •INDICATIONS
- •GOALS
- •Target pressure
- •TYPES OF TREATMENT
- •PROGNOSIS
- •THE GLAUCOMA SUSPECT AND OCULAR HYPERTENSION
- •EPIDEMIOLOGY OF OCULAR HYPERTENSION
- •RISK FACTORS FOR DEVELOPMENT OF OPEN-ANGLE GLAUCOMA
- •TREATMENT
- •NORMAL-TENSION GLAUCOMA
- •PATHOGENESIS
- •CLINICAL FEATURES
- •DIFFERENTIAL DIAGNOSIS
- •WORK-UP
- •TREATMENT
- •REFERENCES
- •Secondary open angle glaucoma
- •PIGMENTARY GLAUCOMA
- •EXFOLIATION SYNDROME (PSEUDOEXFOLIATION SYNDROME)
- •CORTICOSTEROID GLAUCOMA
- •LENS-INDUCED GLAUCOMA
- •PHACOLYTIC GLAUCOMA
- •LENS-PARTICLE GLAUCOMA
- •PHACOANAPHYLAXIS
- •GLAUCOMA AFTER CATARACT SURGERY
- •GLAUCOMA FROM VISCOELASTIC SUBSTANCES
- •GLAUCOMA WITH PIGMENT DISPERSION FROM INTRAOCULAR LENSES
- •UVEITIS-GLAUCOMA-HYPHEMA SYNDROME
- •GLAUCOMA FROM VITREOUS IN THE ANTERIOR CHAMBER
- •GLAUCOMA AFTER TRAUMA
- •CHEMICAL BURNS
- •ELECTRIC SHOCK
- •RADIATION
- •PENETRATING INJURIES
- •CONTUSION INJURIES
- •GLAUCOMA ASSOCIATED WITH INTRAOCULAR HEMORRHAGE
- •GHOST-CELL GLAUCOMA
- •HEMOLYTIC GLAUCOMA
- •HEMOSIDEROSIS
- •HYPHEMA
- •RETINAL DETACHMENT AND GLAUCOMA
- •SCHWARTZ SYNDROME
- •GLAUCOMA AFTER VITRECTOMY
- •GLAUCOMA WITH UVEITIS
- •FUCHS’ HETEROCHROMIC IRIDOCYCLITIS
- •GLAUCOMATOCYCLITIC CRISIS
- •HERPES SIMPLEX
- •HERPES ZOSTER
- •SARCOIDOSIS
- •JUVENILE RHEUMATOID ARTHRITIS
- •SYPHILIS
- •INTRAOCULAR TUMORS AND GLAUCOMA
- •AMYLOIDOSIS
- •ELEVATED EPISCLERAL VENOUS PRESSURE
- •SUPERIOR VENA CAVA OBSTRUCTIONS
- •THYROID EYE DISEASE
- •ARTERIOVENOUS FISTULAS
- •STURGE-WEBER SYNDROME
- •IDIOPATHIC ELEVATIONS
- •REFERENCES
- •TERMINOLOGY
- •CLASSIFICATION
- •SYNDROME CLASSIFICATION
- •PRIMARY GLAUCOMA
- •CLINICAL ANATOMIC CLASSIFICATION
- •Isolated trabeculodysgenesis
- •Iridodysgenesis
- •Anterior stromal defects
- •Structural iris defects
- •Corneodysgenesis
- •CLINICAL PRESENTATION
- •EXAMINATION
- •Office examination
- •Examination under anesthesia
- •Intraocular pressure measurement
- •Corneal measurements: diameter and central thickness
- •Axial length measurement
- •Gonioscopy
- •Ophthalmoscopy
- •Cycloplegic refraction
- •Systemic evaluation
- •PRIMARY CONGENITAL GLAUCOMA
- •INCIDENCE
- •GENETICS AND HEREDITY
- •PATHOPHYSIOLOGY
- •DIFFERENTIAL DIAGNOSIS
- •Other glaucomas
- •Other causes of corneal enlargement or clouding
- •Other causes of epiphora or photophobia
- •Other optic nerve abnormalities
- •MANAGEMENT
- •Preoperative management
- •Initial surgery
- •Follow-up evaluations
- •Filtering surgery
- •Synthetic drainage devices
- •Cyclodestructive procedures
- •Long-term follow-up, management, and prognosis
- •Late developing primary congenital glaucoma
- •GLAUCOMA ASSOCIATED WITH OTHER CONGENITAL ANOMALIES
- •FAMILIAL HYPOPLASIA OF THE IRIS WITH GLAUCOMA
- •DEVELOPMENTAL GLAUCOMA WITH ANOMALOUS SUPERFICIAL IRIS VESSELS
- •ANIRIDIA
- •STURGE-WEBER SYNDROME (ENCEPHALOFACIAL ANGIOMATOSIS, ENCEPHALOTRIGEMINAL ANGIOMATOSIS)
- •NEUROFIBROMATOSIS (VON RECKLINGHAUSEN’S DISEASE)
- •PIERRE ROBIN AND STICKLER SYNDROMES
- •SKELETAL DYSPLASTIC SYNDROMES
- •CORNEODYSGENESIS
- •Axenfeld’s anomaly
- •Rieger’s anomaly and syndrome
- •PETER’S ANOMALY
- •LOWE SYNDROME (OCULOCEREBRORENAL SYNDROME)
- •MICROCORNEA SYNDROMES
- •RUBELLA
- •CHROMOSOME ABNORMALITIES
- •BROAD THUMB SYNDROME (RUBENSTEIN–TAYBI SYNDROME)
- •SECONDARY GLAUCOMA IN INFANTS
- •PERSISTENT FETAL VASCULATURE (PERSISTENT HYPERPLASITIC PRIMARY VITREOUS)
- •RETINOPATHY OF PREMATURITY (RETROLENTAL FIBROPLASIAS)
- •LENS-RELATED GLAUCOMAS
- •Aphakic pediatric glaucoma
- •Subluxation and pupillary block
- •Marfan syndrome
- •Homocystinuria
- •Spherophakia and pupillary block
- •Weill-Marchesani and GEMSS syndromes
- •TUMORS
- •Retinoblastoma
- •Juvenile xanthogranuloma
- •INFLAMMATION
- •Juvenile rheumatoid arthritis
- •STEROID GLAUCOMA IN CHILDREN
- •NEOVASCULAR GLAUCOMA
- •TRAUMA
- •REFERENCES
- •Genetics of glaucoma
- •BASIC GENETICS
- •GENETIC NOMENCLATURE
- •PRIMARY OPEN-ANGLE, NORMAL-TENSION, AND JUVENILE-ONSET OPEN-ANGLE GLAUCOMA
- •TIGR/MYOCILIN
- •OPTINEURIN
- •OTHER GENES IN OPEN-ANGLE GLAUCOMA
- •EXFOLIATION SYNDROME AND GLAUCOMA
- •GLAUCOMA ASSOCIATED WITH DEVELOPMENTAL DISORDERS
- •PRIMARY CONGENITAL GLAUCOMA
- •AXENFELD-RIEGER ANOMALY
- •ANIRIDIA
- •NAIL PATELLA SYNDROME
- •RENAL TUBULAR ACIDOSIS
- •SUMMARY
- •REFERENCES
- •DIAGNOSIS
- •IDENTIFYING GLAUCOMA SUSPECTS
- •DETERMINING ADEQUACY OF TREATMENT
- •TREATMENT FOLLOW-UP
- •DOCUMENTATION OF PROGRESS
- •PATIENT EDUCATION
- •EFFECTIVE JUDGMENT
- •REFERENCES
- •TARGET PRESSURE
- •MEDICAL THERAPY
- •ADVANTAGES
- •DISADVANTAGES
- •SURGICAL THERAPY
- •ADVANTAGES
- •DISADVANTAGES
- •BASIC PHARMACOLOGY
- •BIOAVAILABILITY OF TOPICAL OCULAR MEDICATION
- •TEAR FILM
- •CORNEAL BARRIERS
- •DRUG FORMULATION
- •DRUG ELIMINATION
- •COMPLIANCE
- •GENERAL SUGGESTIONS FOR MEDICAL TREATMENT OF GLAUCOMA
- •ESTABLISH A TARGET PRESSURE
- •ADJUST THE TREATMENT PROGRAM TO THE PATIENT AND HIS OR HER LIFESTYLE
- •WHEN THERAPY IS INEFFECTIVE, SUBSTITUTE RATHER THAN ADD DRUGS
- •CONTINUALLY MONITOR THE TARGET PRESSURE
- •ASK ABOUT AND MONITOR OCULAR AND SYSTEMIC SIDE EFFECTS
- •SIMPLIFY AND REDUCE TREATMENT WHEN POSSIBLE
- •TEACH PATIENTS THE PROPER TECHNIQUE FOR INSTILLING EYEDROPS
- •PROVIDE WRITTEN INSTRUCTIONS
- •COMMUNICATE WITH THE PATIENT’S FAMILY PHYSICIAN
- •ASK ABOUT PROBLEMS WITH THE MEDICAL REGIMEN
- •CONSIDER DEFAULTING AS AN EXPLANATION FOR THE FAILURE OF MEDICAL TREATMENT
- •EDUCATE PATIENTS ABOUT THEIR ILLNESS AND ITS TREATMENT
- •STOP TREATMENT PERIODICALLY TO DETERMINE CONTINUING EFFECTIVENESS
- •MEASURE INTRAOCULAR PRESSURE AT DIFFERENT TIMES OF THE DAY AND AT DIFFERENT INTERVALS AFTER THE LAST ADMINISTRATION OF MEDICATION
- •RECOMMEND COMPARISON SHOPPING FOR MEDICATIONS
- •SUMMARY
- •REFERENCES
- •Prostaglandins
- •MECHANISM OF ACTION
- •DRUGS IN CLINICAL USE
- •LATANOPROST (XALATAN, PHXA41)
- •BIMATOPROST
- •TRAVOPROST
- •FIXED COMBINATION AGENTS
- •SIDE EFFECTS
- •SUGGESTIONS FOR USE
- •REFERENCES
- •MECHANISM(S) OF ACTION
- •EPINEPHRINE
- •DIPIVEFRIN
- •NOREPINEPHRINE
- •Phenylephrine
- •Clonidine
- •Apraclonidine
- •Brimonidine
- •Isoproterenol
- •Salbutamol
- •Others
- •DOPAMINERGIC AGONISTS
- •ADRENERGIC POTENTIATORS
- •MONOAMINE OXIDASE AND CATECHOL O-METHYLTRANSFERASE INHIBITORS
- •6-HYDROXYDOPAMINE
- •PROTRIPTYLINE
- •GUANETHIDINE (ISMELIN)
- •NONADRENERGIC ACTIVATORS OF ADENYLATE CYCLASE
- •DRUGS IN CLINICAL USE
- •Epinephrine (Eppy, Epinal, Epifrin, and generics)
- •Dipivefrin (Propine and generics)
- •Suggestions for use
- •Side effects
- •Clonidine
- •Prophylaxis in anterior segment laser surgery
- •Argon laser trabeculoplasty
- •Laser iridotomy
- •Nd:YAG laser posterior capsulotomy
- •Management of acute pressure rises
- •Management of open-angle and other chronic glaucomas
- •Combination therapy
- •Side effects
- •Suggestions for use
- •SUMMARY
- •REFERENCES
- •Adrenergic antagonists
- •MECHANISM OF ACTION
- •DRUGS IN CLINICAL USE
- •TIMOLOL MALEATE
- •TIMOLOL HEMIHYDRATE
- •BETAXOLOL
- •LEVOBUNOLOL
- •CARTEOLOL
- •METIPRANOLOL
- •PROPRANOLOL
- •ATENOLOL
- •PINDOLOL
- •NADOLOL
- •METAPROLOL
- •LABETOLOL
- •SUGGESTIONS FOR USE
- •OPEN-ANGLE GLAUCOMA
- •ANGLE-CLOSURE GLAUCOMA
- •SECONDARY GLAUCOMA
- •GLAUCOMA IN CHILDREN
- •BLOOD FLOW AND NEUROPROTECTION
- •SIDE EFFECTS
- •OCULAR
- •SYSTEMIC
- •OTHER ADRENERGIC ANTAGONISTS
- •Thymoxamine
- •Dapiprazole
- •Bunazosin
- •Prazosin
- •Others
- •REFERENCES
- •Carbonic anhydrase inhibitors
- •MECHANISM OF ACTION
- •DIRECT EFFECT ON AQUEOUS HUMOR FORMATION
- •INDIRECT EFFECT ON AQUEOUS HUMOR FORMATION
- •DRUGS IN CLINICAL USE
- •TOPICAL CARBONIC ANHYDRASE INHIBITORS
- •Dorzolamide
- •Brinzolamide
- •SYSTEMIC CARBONIC ANHYDRASE INHIBITORS
- •Acetazolamide
- •Methazolamide
- •Ethoxzolamide
- •Dichlorphenamide
- •SIDE EFFECTS
- •TOPICAL CARBONIC ANHYDRASE INHIBITORS
- •ORAL CARBONIC ANHYDRASE INHIBITORS
- •CONTRAINDICATIONS
- •Acidosis and sickling of red blood cells
- •Other severe symptoms
- •Retinal-choroidal blood flow and neuroprotection
- •SUGGESTIONS FOR USE
- •ANGLE-CLOSURE GLAUCOMA
- •OPEN-ANGLE GLAUCOMA
- •SECONDARY GLAUCOMA
- •INFANTILE AND JUVENILE GLAUCOMA
- •OTHER USES
- •REFERENCES
- •Cholinergic drugs
- •MECHANISMS OF ACTION
- •ANGLE-CLOSURE GLAUCOMA
- •OPEN-ANGLE GLAUCOMA
- •DRUGS IN CLINICAL USE
- •DIRECT-ACTING CHOLINERGIC AGENTS
- •Acetylcholine
- •Pilocarpine
- •Alternative drug delivery systems
- •Methacholine (Mecholyl)
- •Carbachol
- •Aceclidine (Glaucostat)
- •INDIRECT (ANTICHOLINESTERASE) AGENTS
- •Echothiophate iodide (phospholine iodide)
- •Demecarium bromide (Humorsol, Tosmilen)
- •Isoflurophate (Floropryl, di-isopropyl fluorophosphate, Dyflos)
- •Physostigmine (eserine)
- •Neostigmine (prostigmine)
- •SIDE EFFECTS
- •OCULAR
- •SYSTEMIC
- •SUGGESTIONS FOR USE
- •EXAMINATION
- •CONTRAINDICATIONS
- •REFERENCES
- •Hyperosmotic agents
- •MECHANISMS OF ACTION
- •DRUGS IN CLINICAL USE
- •ORAL AGENTS
- •Glycerol
- •Isosorbide
- •Ethyl alcohol
- •INTRAVENOUS AGENTS
- •Mannitol
- •Urea
- •SIDE EFFECTS
- •SUGGESTIONS FOR CLINICAL USE
- •ANGLE-CLOSURE GLAUCOMA
- •SECONDARY GLAUCOMA
- •CILIARY BLOCK (MALIGNANT) GLAUCOMA
- •TOPICAL HYPEROSMOTIC AGENTS
- •OTHER
- •REFERENCES
- •General aspects of laser therapy
- •GENERAL ASPECTS OF LASER THERAPY
- •TISSUE EFFECTS OF LASER
- •THERMAL EFFECTS (PHOTOCOAGULATION, PHOTOVAPORIZATION)
- •PHOTODISRUPTION
- •PHOTOABLATION
- •PHOTOCHEMICAL EFFECTS
- •GENERAL PREPARATION OF THE PATIENT
- •BASIC LASER SAFETY
- •REFERENCES
- •LASER PERIPHERAL IRIDOTOMY
- •INDICATIONS
- •TYPES OF LASER
- •GENERAL PREPARATION
- •ND:YAG LASER IRIDOTOMY
- •ARGON OR SOLID-STATE LASER IRIDOTOMY
- •LIGHT BROWN IRIS
- •Dark brown iris
- •Light blue iris
- •COMPLICATIONS OF LASER IRIDOTOMY
- •Iritis
- •Pressure elevation
- •Cataract
- •Hyphema
- •Corneal epithelial injury
- •Endothelial damage
- •Corneal stroma
- •Failure to perforate
- •Late closure
- •Retinal burn
- •Aphakia and pseudophakia with pupillary block
- •LASER IRIDOPLASTY (GONIOPLASTY)
- •PLATEAU IRIS
- •NANOPHTHALMOS
- •LASERS IN MALIGNANT GLAUCOMA
- •REFERENCES
- •LASER TRABECULOPLASTY
- •HISTORY
- •RESULTS
- •SELECTIVE LASER TRABECULOPLASTY
- •Concept
- •Mechanism
- •Technique
- •Patient preparation
- •Procedure
- •POSTOPERATIVE TREATMENT
- •OUTCOMES
- •CONTRAINDICATIONS
- •AS INITIAL THERAPY
- •PREDICTORS OF OUTCOME
- •APHAKIC AND PSEUDOPHAKIC OPEN-ANGLE GLAUCOMA
- •COMPLICATIONS
- •Intraocular pressure elevation
- •Sustained intraocular pressure increase
- •Hyphema
- •Peripheral anterior synechiae
- •Iritis
- •Uveitis
- •EXCIMER LASER TRABECULOSTOMY
- •Concept
- •Technique
- •Outcomes
- •OTHER LASER SCLEROSTOMY TECHNIQUES
- •REFERENCES
- •CYCLOPHOTOCOAGULATION
- •OTHER LASER PROCEDURES
- •SEVERING OF SUTURES
- •REOPENING FAILED FILTRATION SITES
- •CYCLODIALYSIS AND LASER
- •LASER SYNECHIALYSIS
- •GONIOPHOTOCOAGULATION
- •PHOTOMYDRIASIS (PUPILLOPLASTY)
- •REFERENCES
- •General surgical care
- •THE SURGICAL DECISION
- •PREOPERATIVE CARE
- •INSTRUCTIONS TO THE PATIENT
- •OUTPATIENT VERSUS INPATIENT SURGERY
- •PREOPERATIVE MEDICATIONS
- •OPERATIVE CARE
- •THE OPERATING ROOM
- •ANESTHESIA
- •EQUIPMENT
- •POSTOPERATIVE CARE
- •ACTIVITY
- •MEDICATIONS
- •REFERENCES
- •Glaucoma outflow procedures
- •GENERAL CONSIDERATIONS
- •EXTERNAL FILTRATION SURGERY
- •GUARDED PROCEDURES
- •FULL-THICKNESS PROCEDURES
- •RESULTS OF EXTERNAL FILTRATION SURGERY
- •THE CONJUNCTIVAL FLAP
- •LIMBUS-BASED FLAP
- •FORNIX-BASED FLAP
- •EXCISION OF TENON’S CAPSULE
- •GUARDED FILTRATION PROCEDURE
- •TRABECULECTOMY
- •Indications
- •Standard technique
- •Moorfields Safer Surgery System technique
- •Results
- •Surgical options and modifications
- •Triangular versus rectangular flap
- •Postoperative lasering, adjustment, or release of sutures
- •Wound-healing retardants
- •FULL-THICKNESS FILTRATION PROCEDURES
- •THERMAL SCLEROSTOMY (SCHEIE PROCEDURE)
- •SCLERECTOMY
- •Posterior lip sclerectomy
- •Anterior lip sclerectomy
- •TREPHINATION
- •IRIDENCLEISIS
- •GLAUCOMA DRAINAGE DEVICES
- •THE MOLTENO IMPLANT
- •Techniques
- •SCHOCKET PROCEDURE
- •KRUPIN VALVE AND EX-PRESS IMPLANT
- •AHMED VALVE
- •BAERVELDT IMPLANT
- •RESULTS AND COMPLICATIONS OF DRAINAGE DEVICES
- •REFERENCES
- •CATARACT SURGERY IN THE GLAUCOMATOUS EYE
- •TYPES OF GLAUCOMA AND THEIR INFLUENCE ON CATARACT MANAGEMENT
- •SELECTING THE APPROPRIATE SURGICAL APPROACH
- •SELECTING THE APPROPRIATE PROCEDURE: HISTORICAL CONSIDERATIONS
- •SURGICAL TECHNIQUES FOR COMBINED PROCEDURES
- •GENERAL PREOPERATIVE CONSIDERATIONS
- •SMALL-INCISION COMBINED SURGERY
- •Incision sites
- •Fornix versus limbal conjunctival flap
- •Scleral flap
- •Antimetabolite use
- •Managing the small pupil
- •Phacoemulsification techniques
- •Intraocular lens selection
- •Trabeculectomy formation
- •Flap closure
- •Postoperative medical management
- •EXTRACAPSULAR CATARACT EXTRACTION COMBINED SURGERY
- •Miotic pupil
- •Incision construction
- •CATARACT SURGERY WITH PRE-EXISTING FILTRATION BLEB
- •REFERENCES
- •BUTTONHOLING THE CONJUNCTIVA
- •THE SHALLOW AND FLAT ANTERIOR CHAMBER
- •FLAT ANTERIOR CHAMBER WITH HYPOTONY
- •FLAT ANTERIOR CHAMBER IN NORMOTENSIVE AND HYPERTENSIVE EYES
- •CILIARY BLOCK (MALIGNANT GLAUCOMA)
- •SUPRACHOROIDAL HEMORRHAGE (SCH)
- •INTRAOPERATIVE FLAT ANTERIOR CHAMBER
- •HYPHEMA
- •LARGE HYPHEMA
- •INTRAOCULAR INFECTION
- •SYMPATHETIC OPHTHALMIA
- •FILTRATION FAILURE
- •DIGITAL PRESSURE
- •FAILURE DURING THE FIRST POSTOPERATIVE WEEK
- •PLUGGED SCLEROSTOMY SITE
- •RETAINED VISCOELASTIC MATERIAL
- •TIGHT SCLERAL FLAP: RELEASABLE SUTURES AND LASER SUTURE LYSIS
- •INADEQUATE OPENING OF DESCEMET’S MEMBRANE
- •ENCAPSULATED BLEB
- •REOPERATION AFTER FAILED FILTRATION
- •REVISION OF ENCYSTED BLEB
- •Needling of failed blebs
- •Slit-lamp or minor surgery setting
- •Operating room setting
- •FAILED FILTRATION WITH NO BLEB
- •BLEB COMPLICATIONS AND MANAGEMENT
- •THIN-WALLED BLEBS
- •DIFFUSE BLEBS
- •OVERFUNCTIONING BLEBS
- •DELLEN
- •HYPOTONOUS MACULOPATHY
- •LATE HYPOTONY AFTER FILTERING SURGERY
- •HYPOTONY WITH OCCULT FILTERING ‘BLEB’
- •HYPOTONY WITH OCCULT CYCLODIALYSIS CLEFTS
- •HYPOTONY WITH AQUEOUS SUPPRESSION THERAPY IN CONTRALATERAL EYE
- •HYPOTONY FROM RETINAL DETACHMENT
- •HYPOTONY FROM IRITIS OR ISCHEMIA
- •REFERENCES
- •SURGERY FOR INFANTILE AND JUVENILE GLAUCOMA
- •GONIOTOMY
- •Preoperative considerations
- •Intraoperative procedures
- •Complications
- •Practice goniotomy
- •Other ab-interno angle surgery
- •TRABECULOTOMY AB EXTERNO
- •EVALUATION OF GONIOTOMY AND TRABECULOTOMY
- •COMBINED TRABECULOTOMY AND TRABECULECTOMY
- •TRABECULODIALYSIS
- •MISCELLANEOUS PROCEDURES
- •Goniosynechialysis
- •Cyclocryotherapy
- •Retrobulbar alcohol injection
- •Earlier procedures
- •REFERENCES
- •New ideas in glaucoma surgery
- •INTRODUCTION
- •NON-PENETRATING GLAUCOMA SURGERY
- •VISCOCANALOSTOMY
- •BYPASS INTRASCLERAL CHANNELS (NON-PENETRATING DEEP SCLERECTOMY)
- •SHUNTS INTO SCHLEMM’S CANAL
- •TRABECTOME®
- •SHUNTS INTO THE SUPRACHOROIDAL SPACE
- •SUMMARY
- •REFERENCES
- •Challenges for the new century
- •PATHOPHYSIOLOGY
- •CLASSIFICATION AND DIAGNOSIS
- •SCREENING
- •TREATMENT
- •CONCLUSION
- •REFERENCES
- •Appendix
- •GLAUCOMA CONSENSUS
- •GLAUCOMA DIAGNOSIS – STRUCTURE AND FUNCTION (2004)
- •CONSENSUS STATEMENTS
- •Structure
- •Function
- •Function and structure
- •GLAUCOMA SURGERY – OPEN ANGLE GLAUCOMA (2005)
- •CONSENSUS STATEMENTS
- •Indications for glaucoma surgery
- •Argon laser trabeculoplasty
- •Wound healing
- •Trabeculectomy
- •Combined cataract/trabeculectomy
- •Aqueous shunting procedures with glaucoma drainage devices
- •Comparison of procedures: trabeculectomy versus aqueous shunting procedures with glaucoma drainage devices
- •Non-penetrating glaucoma drainage surgery
- •Comparison of trabeculectomy with non-penetrating drainage glaucoma surgery in open-angle glaucoma
- •Cyclodestruction
- •Comparison of cyclophotocoagulation and glaucoma drainage device implantation
- •ANGLE CLOSURE AND ANGLE-CLOSURE GLAUCOMA (2006)
- •CONSENSUS STATEMENTS
- •Management of acute angle closure crisis
- •Surgical management of primary angle-closure glaucoma
- •Laser and medical treatment of primary angle-closure glaucoma
- •Laser and medical treatment of primary angle-closure glaucoma
- •Detection of primary angle closure and angle-closure glaucoma
- •INTRAOCULAR PRESSURE (2007)
- •CONSENSUS STATEMENTS
- •Measurement of intraocular pressure
- •Intraocular pressure as a risk factor for glaucoma development & progression
- •Epidemiology of intraocular pressure
- •Clinical trials and intraocular pressure
- •Target intraocular pressure in clinical practice
- •Index
|
chapter |
Developmental and childhood glaucoma |
19 |
|
|
membrane involving the visual axis and anisometropia. Although the amount of myopia that is induced by the stretching of the infant globe can be neutralized by the flattening of the cornea, this myopia is often significant. Irregular astigmatism also is evident in many cases. A cycloplegic refraction should be performed as soon as possible and should be followed by frequent adjustments in lens power as the anisometropia changes. Appropriate occlusion therapy must be started as soon as amblyopia is recognized. Even brief periods of corneal clouding can cause deprivation amblyopia. Thus coordination of eye care with ophthalmologists interested in pediatric management can often maximize the child’s visual rehabilitation.
Long-term medical therapy in children can be difficult to maintain because of side effects and compliance problems. Moreover, few antiglaucoma medications have been studied in children, and they are mostly used either in a presurgical context or as an adjunct to partially successful surgery.
-Blockers, such as timolol 0.25%, are well tolerated in most patients who do not have asthma or heart disease.110,111 Selective 1-
adrenergic antagonists, such as betaxolol, may further decrease the incidence of pulmonary side effects. Newer topical agents, such as the agonists, prostaglandins, and topical carbonic anhydrase inhibitors, can also be used, but possible side effects must be monitored.As noted above, brimonidine should be avoided in children under 5 years of age. Coordination of the glaucoma medical regimen with the child’s pediatrician is advised. Generally, if an increasing number of topical drops is required for IOP control, further surgery may be indicated.
Patients with primary congenital glaucoma require regular
examinations throughout life. Increases in IOP, corneal edema, and retinal detachment165,166 can occur at any time and must be
detected as soon as possible and treated appropriately. The long-
term prognosis for IOP control in successfully treated cases of primary congenital glaucoma appears excellent,113,167 although late
relapses have been observed up to 15 years later.116 Most patients with primary congenital glaucoma successfully treated in infancy have maintained good pressure control with stable optic nerves and fully functional visual fields into adulthood.
Late developing primary congenital glaucoma
Late developing primary congenital glaucoma occurs in children whose IOP becomes elevated after the age of approximately 3, when corneal enlargement or significant symptoms no longer occur. The angle may have the appearance of isolated trabeculodysgenesis with a flat or concave insertion, or the angle anomaly may be indefinite with a partial development of the angle recess. Some authors group this presentation of glaucoma in the ‘juvenile’ category.13 This disorder may be difficult to distinguish from early developing primary open-angle glaucoma.
Initially, medical treatment should be attempted. Innovative laser treatments of the angle have been described,168,169 but they are not
widely available. In the event that surgery is required, a trabeculotomy ab externo is the initial surgical procedure of choice in children this age.
pupillary sphincter, trabeculodysgenesis, and glaucoma; this has also been referred to as iridogoniodysgenesis.The anterior stroma of the iris is markedly hypoplastic, and the pupillary sphincter is obvious as a tan distinct ring around the pupil. Glaucoma may occur at any time from birth until late adulthood; the striking iris appearance correlates with eventual glaucoma in 100% of cases. Childhood cases respond well to goniotomy or trabeculotomy. Cases with later onset have been managed successfully with medical therapy, argon laser trabeculoplasty, trabeculotomy, or trabeculectomy.
Its hereditary pattern is autosomal dominant.172 Early studies had found genetic linkage of iris hypoplasia to the Rieger’s syndrome locus at 4q25,173 but others considered this association inconsistent.174 A recent comprehensive review of the literature identifies a total of three causative loci (4q25, 6p25, and 13q14) and persuasively argues for retaining the broader clinical term ‘AxenfeldRieger syndrome’ to embrace a wide range of phenotypic subtypes (viz.,Axenfeld anomaly, Rieger anomaly, Rieger syndrome, iridogoniodysgenesis anomaly, iridogoniodysgenesis syndrome, iris hypoplasia, and familial glaucoma iridogoniodysplasia).175 This illustrates that there may be a significant difference in the clinical classification of the developmental glaucomas (i.e., autosomal dominant iris hypoplasia and autosomal dominant juvenile glaucoma share a common clinical presentation but different chromosomal defects) and the genetic associations discovered by molecular biology (i.e., iris hypoplasia and Rieger’s syndrome are linked on chromosome 4, but may appear very different from one another).9 From the patient’s vantage, any of these genetic aberrations or phenotypic expressions confer a 50% greater chance of developing glaucoma than would otherwise be recognized.
Developmental glaucoma with anomalous superficial iris vessels
Irregularly wandering superficial iris vessels with distortion or absence of the superficial iris stroma and distortion of the pupil are commonly seen in newborn children with glaucoma (see Fig. 19-8).The cornea usually is hazy, and the vessels may be difficult to see.These vessels can be differentiated easily from the normal radial
Glaucoma associated with other congenital anomalies
Familial hypoplasia of the iris with glaucoma
Familial hypoplasia of the iris with glaucoma (Fig. 19-23)170,171 is characterized by hypoplasia of the anterior iris stroma, a prominent
Fig. 19-23 Familial hypoplasia of iris with glaucoma. This patient’s mother and son have the same iris appearance and glaucoma. Anterior iris stroma is absent with the exception of a few strands nasally. The sphincter is a prominent ring contrasted against the dark slate-gray appearance of the peripheral iris.
311
part
4 clinical entities
Fig. 19-24 Edge of lens seen in aniridia shows absence of iris. Epithelial keratopathy is clearly visible in lower nasal portion, and a dense cataract is dislocated superiorly.
iris vessels, which are straight and have no associated distortion of the iris tissue.The normal radial iris vessels frequently are visible at birth, before the anterior stroma and its pigmentation have developed completely.
Superficial anomalous iris vessels in children are usually bilateral and resistant to therapy. Early trabeculotomy offers the most hope. Goniotomy can be performed in the least cloudy eye during the same surgery. If the cornea has not cleared dramatically, trabeculotomy or goniotomy should be repeated after 3 or 4 weeks.
Most of these eyes require multiple surgeries and long-term medical therapy. With aggressive management, many can be saved, although vision is rarely normal.
Aniridia
Aniridia (Fig. 19-24) is a bilateral congenital anomaly in which there is profound hypoplasia of the iris in frequent association with multiple ocular anomalies, such as peripheral corneal pannus and keratopathy, foveal hypoplasia, diffuse retinal dysfunction as seen on electroretinography, impaired acuity with nystagmus, cataract and ectopia lentis, and optic nerve hypoplasia.176 Recent studies using ultrasonic biomicroscopy have also documented ciliary body hypopalasia.177 The combination of these defects usually causes a formidable barrier to normal visual function. In addition, 50–75% of aniridics develop glaucoma.178
Two-thirds of patients with aniridia have an affected parent (autosomal dominant form) and one-third represent isolated new mutations.9 The autosomal dominant form without systemic abnormalities accounts for nearly 85% of cases. In the sporadic cases, approximately 20% of patients have been found to have Wilms tumor as part of the multisystem WAGR syndrome (Wilms’ tumoraniridia genitourinary anomalies retardation).173 Thus aniridic children without a family history require co-management with a pediatrician for surveillance of neoplasm and other complications.
The genetic locus of this syndrome for both the sporadic and
familial forms is a mutation of the PAX6 gene on the 11p13 chromosome.179,180 Curiously this is the same defective gene seen in
one case of Peter’s anomaly, although the two clinical syndromes are usually distinct and show little overlap.9,181
Although the defective iris is readily apparent at birth, in most cases glaucoma does not develop until later childhood or early
adulthood, and sometimes does not develop at all.182 In the less frequent infantile-onset cases, the glaucoma is thought to be due to a trabeculodysgenic anomaly of the anterior chamber angle. Because large corneas are rarely seen in aniridic glaucoma, the IOP elevation is presumed to occur at a later developmental stage, usually after age 5 and often into adolescence.Walton178 directly correlates the severity of the glaucoma with the extent of progressive synechial angle closure by the pulled-up residual iris stump.183
The iris is never completely absent; it may vary from being fairly well developed in some areas to being only a rudimentary stump in others. Most commonly, the anterior stroma sweeps up and over the meshwork like concave trabeculodysgenesis.
Corneal dystrophy initially presents as a circumferential and peripheral opacification of the epithelial and subepithelial layers, with vessels advancing into these areas from the limbus. Over many years, this pannus can extend centrally and eventually completely opacify the cornea.
Cataracts develop in most aniridic patients; and the lens may be displaced, with a segmental absence of zonules. Foveal hypoplasia is present in most cases and is clinically appreciated by the appearance of meandering small retinal vessels in what should be the normal avascular zone of the macular region. Vision is usually limited to no better than 20/200, with an accompanying pendular nystagmus. Cases of families with aniridia but normal macular development, no nystagmus, and good vision do occur, implying that the foveal hypoplasia is genetically determined rather than acquired as a result of light damage from lack of iris tissue.184
If aniridic glaucoma occurs in infancy, a trabeculotomy is the procedure of choice because goniotomies are usually unsuccessful if applied after the onset of glaucomatous IOP elevation.178
Encouraging results with trabeculotomy alone,185 trabeculectomy with or without antimetabolites,186–188 or a combination of both
procedures have been reported.189 In mice and in some humans,
one of the defects associated with a Pax 6 mutation is absence of Schemm’s canal.189a We have seen one such infant in which
Schemm’s canal could not be found either clinically or by high resolution ultrasound biomicroscopy.189b This has significant implications for performing trabeculotomy. In older children, medical therapy is indicated as the initial treatment. Surgical complications include direct lens injury and lens or vitreous incarceration in filtration sites; these problems are considerably reduced with the use of intracameral viscoelastic at the time of surgery.
Preventive goniotomy to prevent progressive adherence of the peripheral iris to the trabecular meshwork has been proposed by Walton.190 With a follow-up of over 9 years in 55 eyes which underwent one or more goniotomies at age 3, 90% had normal IOPs without medications – in contrast to the 50% of untreated aniridic eyes expected to develop glaucoma in this time frame.191 This uniquely innovative approach, with its demands for impeccable prophylactic surgery and meticulous follow-up, has yet to be duplicated by other centers.
In cases of failed trabecular surgery, glaucoma implants (e.g.,
Ahmed)192 or ciliodestructive procedures have been used, often with more than two procedures per eye required.146b,193
The cornea may become sufficiently opaque so that penetrating keratoplasty is needed, although the visual results are marginal (one to two lines of improvement in Snellen acuity).194 Lens opacification may require cataract extraction. Before operating, however, the ophthalmologist should attempt refraction through the aphakic portion of the pupil if the lens is subluxated. Either extracapsular or phacoemulsification surgery may be used, depending on
312
|
chapter |
Developmental and childhood glaucoma |
19 |
|
|
the stability of the zonules. Cataract extraction can be difficult and often is accompanied by vitreous loss or further deterioration of the cornea. The use of intraocular lens (IOL) implants in children is an evolving field,195 and whether their alleged ‘protective effect’ in forestalling the additional burden of aphakic glaucoma196 in these aniridic eyes has yet to be determined.
Sturge-weber syndrome (encephalofacial angiomatosis, encephalotrigeminal angiomatosis)
Sturge-Weber syndrome197,198 is characterized by a flat facial hemangioma which follows the distribution of the fifth cranial nerve (Fig. 19-25). The genetic transmission of this disease is unclear. Intracranial abnormalities can produce a spectrum of neurological problems, including seizure disorders in the child.199 For example, the classic meningeal hemangioma may be associated with calcification seen on skull X-ray; other more subtle findings can be neuroimaged with a variety of new techniques.200 The facial hemangioma is usually unilateral but occasionally may be bilateral. Choroidal hemangiomas and episcleral hemangiomas are commonly seen, and leakage from the choroidal hemangioma may cause retinal edema (Fig. 19-26). Such ocular abnormalities can be seen with indocyanine green angiography.201,202
Whereas pediatric glaucoma in aniridia can occur as an infantile trabeculodysgenesis but is more likely to occur later as a secondary glaucoma (progressive angle closure), the glaucoma associated with Sturge-Weber syndrome is more likely to appear in infancy and less often manifests in late childhood or adolescence. SturgeWeber glaucoma is present when the facial hemangioma involves the lids or conjunctiva. Two different mechanisms are thought to be involved. If the glaucoma occurs in infancy, an isolated trabeculodysgenesis type of angle anomaly usually is assumed, described in one case as due to abnormalities in the canal of Schlemm and jux-
tacanalicular tissue.203 Some claim that this is sometimes responsive to goniotomy,204,205 with more than one procedure frequently
required. Medical therapy effectively controls the glaucoma in but
a third of pediatric cases.206
Other authors prefer trabeculotomies,178,207 combined trab-
eculectomy/trabeculotomy,208 or glaucoma tubes, such as an Ahmed valve209,210 or a two-staged Baerveldt procedure.211 As the child ages,
the elevated IOP is due to an elevation of episcleral venous pressure
that occurs as a result of arteriovenous shunts through the episcleral hemangiomas (Fig. 19-27).212,213 In older children, medical therapy
may be better tolerated and effective, with fewer side effects. If medical therapy is unsuccessful, either filtration or tube surgeries can be used.12 In the face of surgical failure, cyclodestructive procedures – cryotherapy,214 diode laser cyclophotocoagulation,157,215,216 or
|
|
|
|
Fig. 19-25 Sturge-Weber |
|
|
|
|
|
||
|
|
|
|
manifestion on face (A) and as a |
|
|
|
|
|
vascular congestion of the episclera |
|
|
|
(B) |
(B). |
||
(A) |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
Fig. 19-26 Hemangioma of the choroid is almost always present in eyes with Sturge-Weber syndrome. In this case, leakage reduced macular acuity.
Fig. 19-27 Note the dense episcleral anastomosis found in surgery. These were not visible until Tenon’s capsule was elevated. Anastomoses can
be cauterized easily and usually do not represent a significant bleeding problem at surgery.
313
part
4 clinical entities
endocyclophotocoagulation217 – can be performed, although more than one intervention is usually required, as is the case in many such difficult pediatric glaucomas.218
In approximately 20% of procedures which penetrate the anterior chamber, such as trabeculectomy, intraoperative or early postoperative choroidal detachment can occur from a rapid expansion of the choroidal hemangioma with effusion of fluid into the suprachoroidal and subretinal spaces (Fig. 19-28).216 Careful attention to maintaining a normal to high IOP during and after surgery
– through the use of an anterior chamber maintainer cannula for constant infusion, generous amounts of viscoelastic, and meticulous wound closure – may forestall intraand perioperative complications. Fortunately, such an event is usually not encountered,208 and prophylactic sclerostomies need not be routinely performed.219 However, the surgeon needs to anticipate such a precipitous event of sudden anterior chamber flattening, which may be impossible to re-form through the surgical site or paracentesis site. Posterior sclerotomy followed by anterior chamber reformation should be performed in an attempt to drain fluid from the suprachoroidal space. Extreme caution is advised: the choroid must not be penetrated, to avoid a catastrophic hemorrhage.
If these efforts are not fully successful, usually in a few days, the expansion subsides as the IOP increases. Repeat filtering surgery can be reconsidered at a later time because the choroidal hemangioma may scar, sometimes enabling the surgeon to successfully perform the procedure without recurrence of the expansion. In such reoperative circumstances, two or three posterior sclerotomies should be preplaced, to prevent this anticipated expansion. Alternatively, a glaucoma valve or shunt, inserting the tube into an eye in which IOP has been carefully maintained by an anterior chamber full of viscoelastic, may be considered after a failed filtering surgery.
There is a classification of neural crest disorders that involve episceral vascular malformations plus ocular hyperpigmentation groups together the Sturge-Weber syndrome, Klippel-Trénaunay- Weber syndrome, oculodermal melanocytosis (nevus of Ota), and phakomatosis pigmentovascularis (a combination of oculodermal melanocytosis and nevus flammeus that is found almost exclusively in Asians).220 When oculodermal melanocytosis and nevus flammeus (phakomatosis pigmentovascularis) occur together, with each extensively involving the globe, there is a strong predisposition for congenital glaucoma. When one or both are present with only
partial globe involvement, elevated IOP could develop later in life, and long-term glaucoma surveillance is advised. The vascular malformations appear to play a more important role in the predisposition to glaucoma than the oculodermal melanocytosis.
A related syndrome called cutis marmorata telangiectatica congenita involves periocular vascular anomalies associated either with regional or generalized cutaneous marbling.221 It has also been associated with infantile trabeculodysgenic glaucoma222–225 and, in one report, with intraoperative suprachoroidal hemorrhage.194
Neurofibromatosis (von recklinghausen’s disease)
Neurofibromatosis (Fig. 19-29) is an autosomal dominant disorder with variable expressivity, affecting as many as 1 in 3000 people,226 and manifesting as anomalies of the neuroectoderm and the development of active hamartomas throughout the body.227 The most common form, neurofibromatosis type 1 (NF-1) (von Recklinghausen’s disease), has seven possible manifestations, requiring two for diagnosis: six or more large café-au-lait macules; plexiform neurofibromata; inguinal or axillary freckling; optic glioma; Lisch nodules (melanocytic hamartomas of the iris); distinctive osseous lesions of the sphenoid or long bones; and a first-degree relative with NF-1. (Curiously there is a report of a monozygotic twin with NF-1 and congenital glaucoma – indicating the complexity of genetic manifestation in the disease.)228
Neurofibromatosis type 2 (NF-2) is a rarer disorder associated with bilateral acoustic neuromas or other neural proliferative lesions, such as meningioma, schwannoma, and glioma. Although NF-2’s defining diagnostic criteria are in flux,229 the disease has a very high mortality by the third decade.230
The extensive literature on the ocular findings of NF-1 includes neurofibromatous nodules on the iris and eyelids, with ectropion uvea,231 optic nerve gliomas in as many as 15% of asymptomatic children under age 6,232 and a variety of complications resulting from mass-occupying lesions in the orbit, such as pulsating exophthalmos to sphenoid bone maldevelopment, herniation of brain tissue into the orbit, or proptosis resulting from optic nerve gliomas. Multiple retinal tumors can be seen, including large retinal astrocytic hamartomas, multiple retinal capillary hemangiomas and corkscrew anomalies,233 and combined hamartomas of the retina
|
|
|
Fig. 19-28 (A) On opening this eye for |
|
|
|
|
|
|
|
trabeculectomy, the anterior chamber |
|
|
|
collapsed and could not be reformed |
|
|
|
by injection of balanced salt solution. |
|
|
|
The flap was closed. Postoperative |
|
|
|
ultrasonography revealed this large |
|
|
|
choroidal elevation extending almost |
|
|
|
to the optic nerve posteriorly. (B) |
|
|
|
Serous retinal detachment overlying |
|
|
|
choroidal expansion in a Sturge-Weber |
|
|
|
patient following postsurgical choroidal |
|
|
|
expansion. There was no retinal hole in |
|
|
|
this patient and the detachment resolved |
(A) |
|
(B) |
|
|
spontaneously. |
314
|
|
|
|
|
chapter |
|
|
|
Developmental and childhood glaucoma |
19 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(A) |
(C) |
|
|
|
|
|
|
|
|
|
|
(B) |
(D) |
Fig. 19-29 A 22-year-old patient with neurofibromatosis. (A) External appearance of iris nodules. (B) External view of abnormally pigmented iris.
(C) Goniophotograph. Note the round pupil, absence of angle recess, and high iris insertion. (D) Café-au-lait spot.
and retinal pigment epithelium, resulting in rubeotic glaucoma, vitreous hemorrhage, and retinal detachment.234
A ‘real world’ context for what a general clinician might encounter, however, was suggested by a study of 211 NF-1 patients, whose diagnosis excluded ophthalmologic criteria, and who were then assessed by anamnestically masked observers, to determine the frequency of ophthalmic findings. The most common lesions, often together, were Lisch nodules (88%) and choroidal hamartomas (29%); but enlarged corneal nerves, plexiform neurofibromas, and symtomatic optic nerve gliomas were found in less than 5% of cases.235
Glaucoma may appear up to 50% of the time when neuro fibromas involve the upper eyelid or the eye itself (Fig. 19-30).The anterior chamber angle may take on several appearances.236 Isolated trabeculodysgenesis may be evident. Synechial closure caused by neurofibromatous tissue posterior to the iris or neurofibromatous infiltration of the angle itself, which may be accompanied by synechial closure, may be present. A sheet of avascular, opaque, dense tissue may arise from the periphery of the iris and extend anteriorly into the angle. Later onset glaucoma in neurofibromatosis can
be associated with unilateral ectropion uvea at the pupillary margin.178,237,238 Usually there is accompanying unilateral ptosis with-
out a palpable neurofibroma; the pupil appears larger due to the static iris hyperplasia of the central iris pigment epithelium. This form of iris ectropion glaucoma may also appear as a distinct form, independent of NF-1 or other anterior segment anomalies.239
Fig. 19-30 Plexiform neuroma of the upper lid in this patient with neurofibromatosis. Eye beneath plexiform neuroma had severe glaucoma that had not been diagnosed.
The preferred treatment in infants is usually goniotomy, with trabeculotomy recommended if iris adhesions are prominent. In older children, medical therapy should be tried first, followed by the surgeon’s choice of surgical interventions: trabeculotomy,
315
